Incentives for me-too drugmakers can help fix high drug prices

08/14/2014 | Forbes

Drug prices are incomprehensible and the cost of oncology treatments keeps rising, writes Dr. Peter Bach of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center. Incentives should be in place for drugmakers to bring me-too treatments to market in order to undercut the prices of competing therapies, and insurers' policies should help those companies gain market share, Bach writes.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT